A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
BioXcel Therapeutics Inc
University of Utah
RECORDATI GROUP
Medical College of Wisconsin
Georgetown University
Xencor, Inc.
Medical College of Wisconsin
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University of Southern California
Stanford University
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Rutgers, The State University of New Jersey